Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence

BlaI is a repressor of BlaZ, the beta-lactamase responsible for penicillin resistance in Staphylococcus aureus. Through screening a transposon library in S. aureus Newman for susceptibility to cathelicidin antimicrobial peptide, we discovered BlaI as a novel cathelicidin resistance factor. Additionally, through integrational mutagenesis in S. aureus Newman and MRSA Sanger 252 strains, we confirmed the role of BlaI in resistance to human and murine cathelidicin and showed that it contributes to virulence in human whole blood and murine infection models. We further demonstrated that BlaI could be a target for innate immune-based antimicrobial therapies; by removing BlaI through subinhibitory concentrations of 6-aminopenicillanic acid, we were able to sensitize S. aureus to LL-37 killing.

[1]  V. Nizet,et al.  β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus , 2013, Antimicrobial Agents and Chemotherapy.

[2]  S. Mobashery,et al.  Dissection of events in the resistance to β-lactam antibiotics mediated by the protein BlaR1 from Staphylococcus aureus. , 2012, Biochemistry.

[3]  J.,et al.  The New England Journal of Medicine , 2012 .

[4]  S. Mobashery,et al.  Activation of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus, Its Proteolytic Processing, and Recovery from Induction of Resistance* , 2011, The Journal of Biological Chemistry.

[5]  V. Nizet,et al.  Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. Krippahl,et al.  Evidence for a purifying selection acting on the β-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus , 2011, BMC Microbiology.

[7]  S. Mobashery,et al.  Binding of the gene repressor BlaI to the bla operon in methicillin-resistant Staphylococcus aureus. , 2010, Biochemistry.

[8]  S. Cole,et al.  Genome‐wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis , 2009, Molecular microbiology.

[9]  V. Nizet,et al.  M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition , 2009, Journal of Innate Immunity.

[10]  K. Sayama,et al.  Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. , 2008, The Journal of antimicrobial chemotherapy.

[11]  O. Schneewind,et al.  Genome Sequence of Staphylococcus aureus Strain Newman and Comparative Analysis of Staphylococcal Genomes: Polymorphism and Evolution of Two Major Pathogenicity Islands , 2007, Journal of bacteriology.

[12]  V. Nizet Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. , 2007, The Journal of allergy and clinical immunology.

[13]  R. Proctor,et al.  In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. , 2007, Microbiology.

[14]  H. Sahl,et al.  The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.

[15]  V. Nizet,et al.  The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  V. Nizet Antimicrobial peptide resistance mechanisms of human bacterial pathogens. , 2006, Current issues in molecular biology.

[17]  S. Mobashery,et al.  β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome , 2005, Cellular and Molecular Life Sciences.

[18]  V. Nizet,et al.  Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. , 2005, The Journal of clinical investigation.

[19]  V. Nizet,et al.  Mutational analysis of the group A streptococcal operon encoding streptolysin S and its virulence role in invasive infection , 2005, Molecular microbiology.

[20]  G. Archer,et al.  Crystal Structures of the BlaI Repressor from Staphylococcus aureus and Its Complex with DNA: Insights into Transcriptional Regulation of the bla and mec Operons , 2005, Journal of bacteriology.

[21]  K. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[22]  B. Barrell,et al.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Weidenmaier,et al.  Bacterial resistance to antimicrobial host defenses--an emerging target for novel antiinfective strategies? , 2003, Current drug targets.

[24]  Michael Otto,et al.  Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.

[25]  R. Lewis,et al.  MecI represses synthesis from the β-lactamase operon of Staphylococcus aureus , 2000 .

[26]  R. Lewis,et al.  MecI represses synthesis from the beta-lactamase operon of Staphylococcus aureus. , 2000, The Journal of antimicrobial chemotherapy.

[27]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[28]  H. Kalbacher,et al.  Inactivation of the dlt Operon inStaphylococcus aureus Confers Sensitivity to Defensins, Protegrins, and Other Antimicrobial Peptides* , 1999, The Journal of Biological Chemistry.

[29]  A. Conde Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[30]  C. Rubens,et al.  Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. , 1998, Gene.

[31]  E. Maguin,et al.  New thermosensitive plasmid for gram-positive bacteria , 1992, Journal of bacteriology.

[32]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[33]  N. Fairweather,et al.  Expression of a cloned Staphylococcus aureus alpha-hemolysin determinant in Bacillus subtilis and Staphylococcus aureus , 1983, Infection and immunity.

[34]  Eugene Rosenberg,et al.  Adherence of bacteria to hydrocarbons: A simple method for measuring cell‐surface hydrophobicity , 1980 .

[35]  C. O'callaghan,et al.  Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate , 1972, Antimicrobial Agents and Chemotherapy.